The North America Large Molecule Bioanalytical Testing Services Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
When the term "ADME/PK screening" is used, it refers to in vitro methods of examining absorption and metabolism. Prior to the period of clinical investigations, drug metabolism studies were carried out at a late stage of the drug development process. Consequently, insufficient metabolism and PK parameters were the primary cause of NCE failure.
Additionally, it is projected that rising government measures to stop the spread of infectious diseases like Corona and the Ebola virus would expand market potential. The research efforts and the existence of a sizable pipeline of compounds based on biologics,peptides, and amino acids, biologics has been increased. The bioanalysis of big molecules calls for qualified experts and cutting-edge infrastructure and analytical tools. These services are easily accessible from providers of bioanalytical testing services.
The budgetary health of the US government is significantly impacted by rising healthcare spending. The burden placed on the populace to support this spending, such as raising taxes or increasing long-term borrowing, is the main effect of the growth in the government's portion of health care spending. Tax hikes not only reduce the amount of money that businesses and individuals would have for other uses, but they also encourage people to take actions to mitigate their consequences.
The US market dominated the North America Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $881.1 million by 2028. The Canada market is experiencing a CAGR of 10.6% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 9.6% during (2022-2028).
Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.
When the term "ADME/PK screening" is used, it refers to in vitro methods of examining absorption and metabolism. Prior to the period of clinical investigations, drug metabolism studies were carried out at a late stage of the drug development process. Consequently, insufficient metabolism and PK parameters were the primary cause of NCE failure.
Additionally, it is projected that rising government measures to stop the spread of infectious diseases like Corona and the Ebola virus would expand market potential. The research efforts and the existence of a sizable pipeline of compounds based on biologics,peptides, and amino acids, biologics has been increased. The bioanalysis of big molecules calls for qualified experts and cutting-edge infrastructure and analytical tools. These services are easily accessible from providers of bioanalytical testing services.
The budgetary health of the US government is significantly impacted by rising healthcare spending. The burden placed on the populace to support this spending, such as raising taxes or increasing long-term borrowing, is the main effect of the growth in the government's portion of health care spending. Tax hikes not only reduce the amount of money that businesses and individuals would have for other uses, but they also encourage people to take actions to mitigate their consequences.
The US market dominated the North America Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $881.1 million by 2028. The Canada market is experiencing a CAGR of 10.6% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 9.6% during (2022-2028).
Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.
Scope of the Study
By End-user
- SMEs
- Large Firms
By Test Type
- Bioavailability
- ADME
- PD
- Bioequivalence
- Others
By Type
- ADA
- Pharmacokinetics
- Others
By Phase
- Clinical
- Pre-clinical
- With Antibody
- Without Antibody (ELISA Based Assay)
By Therapeutic Areas
- Oncology
- Neurology
- Infectious Diseases
- Cardiology
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Laboratory Corporation Of America Holdings
- IQVIA Holdings, Inc.
- Syneos Health, Inc.
- SGS S.A.
- Intertek Group PLC
- Pace Analytical Services, LLC
- ICON Plc
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Large Molecule Bioanalytical Testing Services Market by End-user
Chapter 5. North America Large Molecule Bioanalytical Testing Services Market by Test Type
Chapter 6. North America Large Molecule Bioanalytical Testing Services Market by Type
Chapter 7. North America Large Molecule Bioanalytical Testing Services Market by Phase
Chapter 8. North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
Chapter 9. North America Large Molecule Bioanalytical Testing Services Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Laboratory Corporation Of America Holdings
- IQVIA Holdings, Inc.
- Syneos Health, Inc.
- SGS S.A.
- Intertek Group PLC
- Pace Analytical Services, LLC
- ICON Plc
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific, Inc.
Methodology
LOADING...
